Hospitalization – Page 24 – Communicable Diseases Research

Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine

Article

Published on 2022-09-082022-11-15
Journal: Frontiers in Immunology [Category] SARS, 치료기술,

The impact of repeated rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2

Article

Published on 2022-09-082022-11-15
Journal: Nature Communications [Category] SARS, 치료제,

Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes

Article

Published on 2022-09-062022-11-15
Journal: Frontiers in Immunology [Category] SARS, 바이오마커, 변종, 진단,

[키워드] actin-binding protein Analysis anti-Spike IgG antibody blood sample Clinical management clinical parameter collected Combination Control correlated COVID-19 COVID-19 disease COVID-19 hospitalization COVID-19 negative COVID-19 patient COVID-19 severity CRP CRP-C-reactive protein cytokine death develop disease disease pathogenesis expression ferritin Gelsolin greater health system healthy individuals Hospitalization hospitalized COVID-19 patient IgG IL-6 IMPROVE innate immune Intervention involved IP-10 Laboratory longitudinal M-CSF marker outcome outcomes plasma platform predict profile prognostic Prognostic marker reduced Research SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein SEM significantly utility viral infections while
[DOI] 10.3389/fimmu.2022.1011084 PMC 바로가기

The impact of the COVID-19 pandemic on stress and other psychological factors in pregnant women giving birth during the first wave of the pandemic

Clinical Trial

Published on 2022-09-052022-10-05
Journal: Reproductive Health [Category] SARS, 임상,

[키워드] acute respiratory syndrome addition Administered affected Analysis Anxiety Anxiety Disorder anxiety level caused clinical collected concern coronavirus correlated correlation Course COVID-19 COVID-19 pandemic Department Depression disease Edinburgh Effect exceptional Factor First wave Germany Gynecology hormone Hospital admission Hospitalization IL-6 impairment increase in interleukin-6 loneliness Maternal Maternal bonding medium mental illness moderate Obstetric pandemic Patient Pregnancy pregnant women Psychological Psychosocial stress questionnaire recruited response resulting SARS-CoV-2 SARS-COV-2 infection scale Self-efficacy significant increase Sociodemographic Stress stress symptoms Trial registration university women
[DOI] 10.1186/s12978-022-01493-9 PMC 바로가기 [Article Type] Clinical Trial

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021

Article

Published on 2022-09-022022-11-16
Journal: BMC Medicine [Category] SARS, 변종,

[키워드] adjusted Admissions age AZD1222 BNT162b2 booster Care change changes in Cohort studies cohort study Combination Comorbidities conditions confidence interval country covariate COVID-19 COVID-19 vaccine COVID-19 vaccines death delta variant dominant dose effective Effectiveness facilitated groups hazard heterologous schedules highest hospitalisation hospitalisations Hospitalization Infection intensive care intensive care units knowledge Mortality mRNA mRNA-1273 National Norway pandemic population-based cohort proportional hazards models provided receiving regimen regimens registries remained SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections second dose Sex Support the vaccine vaccination Vaccine vaccine dose vaccine effectiveness waned
[DOI] 10.1186/s12916-022-02480-4 PMC 바로가기

Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers

Article

Published on 2022-09-022022-11-15
Journal: Vaccine [Category] SARS, 변종, 진단,

[키워드] antibody waning binding BNT162b2 booster dose carried caused Cohort Comirnaty comparable COVID-19 deaths decrease Delta wave ELISA assay first dose Follow-up healthcare worker Hospitalization humoral immune response IgG IgG antibodies IgG antibody IgG ELISA IgG level immune response infected with SARS-CoV-2 Infection less longitudinal longitudinal analysis mass median median value N antigen naïve Novel coronavirus observation period of BNT162b2 participant reducing Romania SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-CoV-2 immune response. second dose Spread subset Test the disease the median the patient uninfected participant vaccination Vaccine variants virus wild type
[DOI] 10.1016/j.vaccine.2022.07.040 PMC 바로가기

Epidemiology and Transmission Dynamics of COVID-19 in an Urban Pediatric US Population

Observational Study

Published on 2022-09-012022-10-04
Journal: Public health reports (Washington, D.C. : 1974) [Category] COVID19(2023년), SARS, 임상,

Differences in lung function between major race/ethnicity groups following hospitalization with COVID-19

Research article

Published on 2022-09-012022-10-05
Journal: Respiratory medicine [Category] 유전자 메커니즘,

Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression

COVID-19 질병 진행의 조기 검출을위한 후보 바이오 마커로서 혈청 스트라 티핀 및 프리 셉신

Article

Published on 2022-09-012022-08-31
Journal: Journal of pharmacological sciences [Category] MERS, 바이오마커, 진단, 치료기술, 치료제,

[키워드] Biomarker Biomarkers changes in Cohort collected condition COVID-19 COVID-19 disease COVID-19 patient COVID-19 patients COVID-19 pneumonia COVID-19 progression Critical elevated FIVE Hospitalization independent kallistatin Like lung oxygen oxygen support Patient patients Pneumonia Predictive predictive biomarker Presepsin Prognosis prognosis of patient prognostic biomarker Prognostic biomarkers progression remained reported Serum level serum levels serum sample serum samples Severe case severe cases severe COVID-19 significantly significantly higher Stage stratifin Stratifin. Symptom the patient
[DOI] 10.1016/j.jphs.2022.06.002 PMC 바로가기 [Article Type] Article

Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant

코로나19 델타 변이형 환자에서 카시리비맙-임데비맙 항체 병용요법의 임상적 효능

Article

Published on 2022-09-012022-09-11
Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 변종, 임상, 진단, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus 2 administration age antibody cocktail antibody combination antibody treatment Casirivimab Casirivimab-imdevimab treatment clinical Clinical efficacy cocktail Combination conducted control group coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient death Delta delta variant dose Efficacy evaluate FIVE High flow nasal cannula high-risk patient High-risk patients hospital Hospitalization Imdevimab inclusion criteria intravenously Japan mechanical ventilation monoclonal antibodies monoclonal antibody nasal nasal cannula Neutralizing antibodies outcome oxygen Oxygen therapy Patient patients with COVID-19 receive reduce reduced respiratory risk SARS-CoV-2 significantly lower therapy Treatment treatment group Viral Viral load with COVID-19
[DOI] 10.1016/j.jiac.2022.05.012 PMC 바로가기 [Article Type] Article